IRME
Price:
$0.12
Market Cap:
$8.64M
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.
Industry
Medical - Devices
IPO Date
2021-01-26
Stock Exchange
PNK
Ticker
IRME
According to IR-Med Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.00. This represents a change of -78.82% compared to the average of -18.88 of the last 4 quarters.
The mean historical PE Ratio of IR-Med Inc. over the last ten years is -75.74. The current -4.00 PE Ratio has changed 428.12% with respect to the historical average. Over the past ten years (40 quarters), IRME's PE Ratio was at its highest in in the March 2025 quarter at 0. The PE Ratio was at its lowest in in the September 2020 quarter at -293.97.
Average
-75.74
Median
-37.31
Minimum
-202.93
Maximum
-3.57
Discovering the peaks and valleys of IR-Med Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 355.30%
Maximum Annual PE Ratio = -3.57
Minimum Annual Increase = -90.43%
Minimum Annual PE Ratio = -202.93
Year | PE Ratio | Change |
---|---|---|
2024 | -17.35 | 6.71% |
2023 | -16.26 | 355.30% |
2022 | -3.57 | -90.43% |
2021 | -37.31 | -41.64% |
2020 | -63.93 | -66.14% |
2019 | -188.83 | -6.95% |
The current PE Ratio of IR-Med Inc. (IRME) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.39
5-year avg
-27.69
10-year avg
-75.74
IR-Med Inc.’s PE Ratio is less than ImpediMed Limited (-3.24), less than VentriPoint Diagnostics Ltd. (-4.00), less than Next Science Limited (-1.51), greater than BioNexus Gene Lab Corp. (-22.65), less than CB Scientific, Inc. (-3.34),
Company | PE Ratio | Market cap |
---|---|---|
-3.24 | $75.83M | |
-4.00 | $17.63M | |
-1.51 | $16.07M | |
-22.65 | $4.80M | |
-3.34 | $3.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IR-Med Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IR-Med Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is IR-Med Inc.'s PE Ratio?
How is the PE Ratio calculated for IR-Med Inc. (IRME)?
What is the highest PE Ratio for IR-Med Inc. (IRME)?
What is the 3-year average PE Ratio for IR-Med Inc. (IRME)?
What is the 5-year average PE Ratio for IR-Med Inc. (IRME)?
How does the current PE Ratio for IR-Med Inc. (IRME) compare to its historical average?